Acquire the license to the best health content in the world
Contact Us

Second Hypertension Drug Recalled Due to Contamination

Some lots of irbesartan being recalled due to contamination with suspected carcinogen


THURSDAY, Nov. 1, 2018 (HealthDay News) -- Another hypertension drug is being recalled due to contamination that could pose a cancer risk, the U.S. Food and Drug Administration says.

Certain lots of irbesartan are being recalled by SciGen because they contain an industrial chemical that is a suspected carcinogen, CNN reported. The recalled drugs have "Westminster Pharmaceuticals" and "GSMS Inc." on the label.

Another heart drug, valsartan, was recalled recently due to contamination with possible cancer-causing chemicals, CNN reported.

Not all medicines that contain valsartan or irbesartan are being recalled. The new recall covers only about 1 percent of irbesartan drug products available in the United States, according to the FDA.

CNN Article
FDA Recall Alert

Physician's Briefing